SBIR/STTR Research Award

Allosteric Drug Discovery using Quantum Cascade Laser based Anisotropic THz Microscope (QCL-ATM)

Award identifier 820b758c2aa1789c6e273a727ae47e6d5bf8eed7aed0fc3c9a46609f394125cfAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$256,580

Program and phase

STTR · Phase I

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
LONGWAVE PHOTONICS LLC
Proposal award date
2021-08-01
Contract end date
2022-07-31
UEI
ND53H94AU844
Solicitation number
PA20-265
Topic code
400

Research abstract

Allosteric Drug Discovery using Quantum Cascade Laserbased Anisotropic THz Microscope (QCL-ATM) Proposal in Response to NIH/NIGMS STTR PA-20-265 This STTR will result in a commercially viable instrument that will enable critical research in allosteric drugs and protein dynamics. To date allosteric inhibitors are largely found serendipitously. Anisotropic THz microspectroscopy (ATM) uniquely measures the long range structural vibrations which serve as a mechanism for allosteric control. ATM provides a tagless means to experimentally determine allosteric target sites. There are NO commercial methods that provide this information currently. ATM systems used to establish the technique are not accessible to a standard biochemical lab. In this STTR we will develop a compact system for turnkey operation by academic and industrial researchers. This will be achieved by a collaboration of optical engineers and biological physicists with unique expertise required. The system requires 1) high power tunable THz source; 2) THz optical system for micro spectroscopy with polarization control; 3) high sensitivity room temperature detection integrated into the microspectroscopy system; and 4) easy user interface. The LongWave Photonics group has innovated high power compact THz sources (quantum cascade lasers, QCL’s) and turn-key measurement systems based on these sources. The Markelz group at UB has innovated ATM. The system, QCL-ATM, will be a turnkey tabletop instrument. In phase I the QCL-ATM will be developed to directly probe vibrations within molecular standards (e.g. sucrose, fructose, and glucose and the protein crystal tetragonal lysozyme) using polarized THz radiation within the 1.6 – 4.3 THz range of our QCL source and measure the change in absorbance as the relative orientation of the crystal molecular samples and polarization axis is varied. Using this demonstration of an integrated QCL-ATM instrument, we will identify the optical and mechanical tolerances associated with the need to place both the sample and the detector entirely within the near-field region of a focused THz beam as preparation for Phase II which will include measurement of the effect of allosteric drugs on protein vibrations and the development of an automated polarization control module and automated multi-sample platen with repeatable high-precision sample alignment to the interrogating THz beam. The specific aims for Phase I are: Aim 1. Construct and Characterize throughput QCL-ATM Microscope in the Far-field. Aim 2. Characterize anisotropic absorbance with the QCL-ATM for molecular crystal standards. Aim 3. Integrate near field pyroelectric detection into the QCL-ATM prototype and establish equivalence to existing systems by measuring spectra of protein crystalAllosteric Drug Discovery using Quantum Cascade Laserbased Anisotropic THz Microscope (QCL-ATM) Proposal in Response to NIH/NIGMS STTR PA-20-265 We propose to develop a benchtop spectroscopic system for rapid characterization of protein structural dynamics based on terahertz polarimetric spectroscopy (anisotropic terahertz microscopy, or ATM). The unique capability of this system to reveal previously unattainable information builds on the proposer’s previous work by incorporating the recently developed high-power tunable terahertz source: the terahertz quantum cascade laser (QCL). This lower complexity system will enable more researchers to perform studies for the development of allosteric drugs, as well as increase the understanding of the impact of remote small molecule binding and mutation.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

17 SBIR/STTR records share this UEI (2010–2023). Reported award amounts total $6,756,130. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: National Aeronautics and Space Administration, Department of Defense, National Science Foundation, Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.